Known for developing personalized immunotherapies for the treatment of cancer through novel cell and gene therapies, UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., has received FDA approval to expand its human clinical trials into two more types of cancer. Using its ImmuneFx (IFx) cancer vaccine technology that initiates the power … Continue reading Morphogenesis Seeks Skin Cancer Patients for New Clinical Trials